Related Experiment Video
Updated: Jul 3, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Molecular credentialing of rodent bladder carcinogenesis models
Paul D Williams1, Jae K Lee, Dan Theodorescu
1Department of Public Health Sciences, Division of Biostatistics, University of Virginia School of Medicine, Charlottesville, VA 22908-0717, USA.
Summary
This study compares gene expression in rodent and human bladder cancer models. Findings reveal conserved genetic pathways, identifying key genes driving urothelial carcinoma progression in humans.
Area of Science:
- Oncology
- Genomics
- Comparative Pathology
Background:
- Urinary bladder cancer often arises from chemical carcinogen exposure.
- Rodent models using N-butyl-N-(4-hydroxybutyl)-nitrosamine (OH-BBN) mimic human urothelial carcinoma histologically.
- Genetic similarities between rodent models and human bladder cancer are not well understood.
Purpose of the Study:
- To compare gene expression profiles of urothelial carcinoma across mouse, rat, and human species.
- To identify conserved genes and pathways involved in bladder cancer development and progression.
- To validate rodent models for studying human bladder cancer genetics.
Main Methods:
- Comparative analysis of gene expression profiles.
- Utilizing OH-BBN induced rodent bladder tumors.
- Comparing rodent tumor gene expression with human urothelial carcinoma data.
Main Results:
- Many human genes homologous to those in rodent tumors are also dysregulated in human bladder cancer.
- Rodent tumor gene expression profiles more closely resemble invasive human tumors than non-muscle-invasive ones.
- Identified a list of candidate genes with concordant regulation across all three species.
Conclusions:
- Rodent models of chemically induced bladder cancer share significant genetic similarities with human disease.
- Conserved genes highlight potential drivers of urothelial carcinoma progression, particularly towards invasive stages.
- This comparative genomic approach aids in understanding bladder cancer mechanisms and identifying therapeutic targets.

